Cancer Policy OpenAI launches ChatGPT Health to analyze medical records January 16, 2026Vol.52 No.02By Claire Marie Porter
Clinical Roundup Mayo develops AI tool that predicts prostate cancer recurrence January 16, 2026Vol.52 No.02
Sponsored Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology January 09, 2026Vol.52 No.1By Ofer Sharon, Michal Harel and Yehonatan Elon
Drugs & Targets SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology January 09, 2026Vol.52 No.1
Regulatory News ESMO publishes guidances on AI tools for clinicians, patients, and researchersSays one author: “We think there should be some degree of human oversight, otherwise, they can go completely rogue and nobody notices.” December 12, 2025Vol.51 No.45By Sara Willa Ernst
Cancer Policy HHS issues AI strategy for internal agency operations December 12, 2025Vol.51 No.45By Sara Willa Ernst
Cancer Policy AI will determine Medicare prior authorizations in six states under new pilot program December 12, 2025Vol.51 No.45By Sara Willa Ernst
Sponsored Fixing site reads without burning out the readersYunu modernizes clinical trial imaging assessment workflows December 05, 2025Vol.51 No.44By Jeff Sorenson
In Brief Jihad Obeid named assistant vice president for research at MUSC December 05, 2025Vol.51 No.44
Drugs & Targets Université Paris-Saclay, Owkin partner to use AI co-pilot for biology research December 05, 2025Vol.51 No.44
